Aerie Pharma (AERI) Tops Q2 EPS by 24c

Aerie Pharma (NASDAQ: AERI) reported Q2 EPS of ($0.32), $0.24 better than the analyst estimate of ($0.56). Revenue for the quarter came in at $33 million versus the consensus estimate of $32.49 million.

For earnings history and earnings-related data on Aerie Pharma (AERI) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• UBS Upgrades Apollo Tyres (APTY:IN) to Buy
• ICICI Securities Resumes Dalmia Bharat Ltd (DALBHARA:IN) at Add (2)